Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients
      
      
        
      
      
      
      
        
          
          - 
            
Buetti, Niccolò
  Ente Ospedaliero Cantonale, Regional Hospital Locarno, Switzerland - University of Paris, INSERM IAME, U1137, Team DeSCID, Paris, France - Infection Control Program and World Health Organization Collaborating Centre on Patient Safety, University Hospitals and Faculty of Medicine, University of Geneva, Switzerland
          
- 
            
Trimboli, Pierpaolo
  Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland - Clinic for Nuclear Medicine and Competence Center for Thyroid Diseases, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
          
- 
            
Mazzuchelli, Timothy
Ente Ospedaliero Cantonale, Regional Hospital Locarno, Switzerland
          
- 
            
Lo Priore, Elia
Ente Ospedaliero Cantonale, Infection Control Program, Ticino, Switzerland - Ente Ospedaliero Cantonale, Division of Infectious Diseases, Regional Hospital Lugano, Switzerland
          
- 
            
Balmelli, Carlo
Ente Ospedaliero Cantonale, Infection Control Program, Ticino, Switzerland - Ente Ospedaliero Cantonale, Division of Infectious Diseases, Regional Hospital Lugano, Switzerland
          
- 
            
Trkola, Alexandra
  Institute of Medical Virology, University of Zurich, Switzerland
          
- 
            
Conti, Marco
Ente Ospedaliero Cantonale, Regional Hospital Locarno, Switzerland
          
- 
            
Martinetti, Gladys
Laboratory of Microbiology EOLAB, Bellinzona, Switzerland
          
- 
            
Elzi, Luigia
Ente Ospedaliero Cantonale, Regional Hospital Locarno, Switzerland - Division Infectious Diseases, Regional Hospital Bellinzona, Switzerland
          
- 
            
Ceschi, Alessandro
  Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland - Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland - Department of Clinical Pharmacology and Toxicology, University Hospital Zurich and University of Zurich, Switzerland
          
- 
            
Consonni, Vera
Ente Ospedaliero Cantonale, Regional Hospital Locarno, Switzerland
          
- 
            
Ogna, Adam
Ente Ospedaliero Cantonale, Regional Hospital Locarno, Switzerland
          
- 
            
Forni-Ogna, Valentina
  Ente Ospedaliero Cantonale, Regional Hospital Locarno, Switzerland - Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
          
- 
            
Bernasconi, Enos
Ente Ospedaliero Cantonale, Division of Infectious Diseases, Regional Hospital Lugano, Switzerland
          
Show more… 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
        
        Published in:
        
          
            
            - Endocrine. - 2020, vol. 70, p. 454–460
 
       
      
      
      
      
      
       
      
      
      
        
        English
        
        
        
          The length of time a critically ill coronavirus disease 2019 (COVID-19) patient remains infectious and should therefore be isolated remains unknown. This prospective study was undertaken in critically ill patients to evaluate  the reliability of single negative real-time polymerase chain reaction (RT-PCR) in lower tracheal aspirates (LTA) in predicting a second negative test and to analyze clinical factors potentially influencing the viral shedding.  From April 9, 2020 onwards, intubated COVID-19 patients treated in the intensive care unit were systematically evaluated for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by RT-PCR of nasopharyngeal  swabs and LTA. The time to negativity was defined as the time between the onset of symptoms and the viral clearance in LTA. In order to identify risk factors for prolonged viral shedding, we used univariate and multivariate  Cox proportional hazards models. Forty-eight intubated SARS-CoV-2 patients were enrolled. Overall, we observed that the association of the first negative RT-PCR with a second negative result was 96.7%. Median viral  shedding was 25 (IQR: 21.5–28) days since symptoms’ onset. In the univariate Cox model analysis, type 2 diabetes mellitus was associated with a prolonged viral RNA shedding (hazard ratio [HR]: 0.41, 95% CI: 0.06–3.11,  p = 0.04). In the multivariate Cox model analysis, type 2 diabetes was associated with a prolonged viral RNA shedding (HR: 0.31, 95% CI: 0.11–0.89, p = 0.029). Intubated patients with type 2 diabetes mellitus may have  prolonged SARS-CoV-2 shedding. In critically ill COVID-19 patients, one negative LTA should be sufficient to assess and exclude infectivity.
        
        
       
      
      
      
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        - 
          Language
        
- 
          
        
- 
          Classification
        
- 
          
              
                
                  Pathology, clinical medicine
                
              
            
          
        
- 
          License
        
- 
          
        
- 
          Open access status
        
- 
          hybrid
        
- 
          Identifiers
        
- 
          
        
- 
          Persistent URL
        
- 
          https://n2t.net/ark:/12658/srd1319149
        
 
   
  
  
  Statistics
  
  
    
      Document views: 176
      
File downloads: